BC
ELV icon

Banced Corp’s Elevance Health ELV Stock Holding History

Banced Corp’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,418
Closed -$373K – 24
2018
Q4 		$373K Sell
1,418
-137
-9% -$37.7K 0.81% 51
2018
Q3 		$426K Sell
1,555
-140
-8% -$36.3K 0.73% 59
2018
Q2 		$403K Sell
1,695
-109
-6% -$25.2K 0.69% 63
2018
Q1 		$396K Sell
1,804
-123
-6% -$28.9K 0.7% 61
2017
Q4 		$433K Buy
1,927
+82
+4% +$17.5K 0.72% 64
2017
Q3 		$351K Buy
+1,845
New +$351K 0.61% 77
2015
Q2 		– Sell
-1,350
Closed -$209K – 156
2015
Q1 		$209K Buy
+1,350
New +$192K 0.3% 145

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Banced Corp's ELV Position: Q1 2019 in Review

Banced Corp sold out of Elevance Health (ELV) in Q1 2019, closing a stake of 1,418 shares — an estimated $373K sold.

Banced Corp first reported a position in ELV in Q1 2015 and held it in 7 quarters. The position peaked at $433K in Q4 2017. 1,074 funds tracked by Wall St. Rank hold ELV as of Q1 2019.

  • Banced Corp reported no remaining Elevance Health position as of Q1 2019 after selling out during the quarter.
  • Banced Corp sold 1,418 Elevance Health shares in Q1 2019, an estimated $373K.
  • Banced Corp first reported a position in Elevance Health in Q1 2015 and held it in 7 quarters.
  • Banced Corp's Elevance Health position peaked at $433K in Q4 2017.
  • 1,074 funds tracked by Wall St. Rank held Elevance Health as of Q1 2019.

Based on Banced Corp's 13F filing for Q1 2019.